Amarin Corp Plc (AMRN)

[hamkypamky]

USA is $0.6B because it's very uncertain jf we can keep our market much less grow share in the remaining 7-8 years of "exclusivity".

1. Sales team hasn't proven very capable.
2. Insurers tightening significantly and requiring more onerous terms and PAs
3. Generics will gradually secure more PIs unless settlement happens

I think there is scope to value US more but the company really needs to show a lot, and I can't overstate that enough, A LOT better results in terms of sales.

Otherwise an acquirer will press the price down like crazy. Remember we're being sold not on what the drug is worth, rather it's what best AMRN can do without a sale plus discount (short of bidding war) now.

I've told this board several times. You're talking about BIG PHARMA. They didn't become BIG pharma by being generous acquirers and foolish with their money. These are sharks who will nickel and dime you all day long and use every dirty trick in the book to make an extra penny.

No BP exec in history is paying $1 if they can get away with paying 99 cents.